Acadia Healthcare (NASDAQ:ACHC) Reaches New 52-Week High on Analyst Upgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) hit a new 52-week high during mid-day trading on Monday after Guggenheim raised their price target on the stock from $26.00 to $31.00. Guggenheim currently has a buy rating on the stock. Acadia Healthcare traded as high as $28.74 and last traded at $29.0760, with a volume of 17545 shares. The stock had previously closed at $27.85.

A number of other brokerages also recently issued reports on ACHC. UBS Group upped their price target on Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a report on Friday, April 17th. Jefferies Financial Group restated a “hold” rating and set a $24.50 price objective on shares of Acadia Healthcare in a research report on Monday, April 20th. Weiss Ratings restated a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, January 21st. Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 price target on the stock in a research note on Monday. Finally, Royal Bank Of Canada boosted their price target on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, February 26th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $25.81.

Institutional Trading of Acadia Healthcare

A number of large investors have recently bought and sold shares of ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in Acadia Healthcare in the first quarter valued at $1,600,000. Goldman Sachs Group Inc. grew its holdings in shares of Acadia Healthcare by 21.1% during the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock worth $21,170,000 after buying an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Acadia Healthcare by 8.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after acquiring an additional 27,207 shares during the period. American Century Companies Inc. raised its stake in Acadia Healthcare by 531.5% during the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock valued at $2,399,000 after acquiring an additional 88,995 shares during the last quarter. Finally, Prudential Financial Inc. lifted its position in Acadia Healthcare by 21.9% during the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after acquiring an additional 1,780 shares during the period.

Acadia Healthcare Stock Up 3.6%

The company has a market capitalization of $2.65 billion, a PE ratio of -2.37, a P/E/G ratio of 9.39 and a beta of 0.73. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The firm has a 50 day simple moving average of $24.43 and a two-hundred day simple moving average of $19.12.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The business had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. During the same quarter in the prior year, the business earned $0.40 earnings per share. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 1.48 EPS for the current year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.